fulvestrant has been researched along with bradykinin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhalla, RC; Gurjar, MV; Sharma, RV; Tan, E | 1 |
| Gyun Jung, C; Hayashi, Y; Hida, H; Kodama, Y; Kohri, K; Mogami, M; Nishino, H | 1 |
| Au, CL; Huang, Y; Laher, I; Leung, FP; Leung, HS; Vanhoutte, PM; Yao, X; Yung, LM | 1 |
3 other study(ies) available for fulvestrant and bradykinin
| Article | Year |
|---|---|
Estrogen receptor-alpha gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration.
Topics: Animals; Aorta; Blotting, Northern; Bradykinin; Cattle; Cell Movement; Cells, Cultured; Endothelium, Vascular; Enzyme Induction; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Gene Expression; Gene Transfer Techniques; Genetic Therapy; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Receptors, Estrogen | 1999 |
Estrogen blocks 3-nitropropionic acid-induced Ca2+i increase and cell damage in cultured rat cerebral endothelial cells.
Topics: Adenosine Triphosphate; Animals; Antihypertensive Agents; Bradykinin; Brain; Calcium; Calcium Signaling; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Fulvestrant; Immunohistochemistry; In Situ Nick-End Labeling; Necrosis; Nitro Compounds; Propionates; Rats; Rats, Wistar; Tamoxifen; von Willebrand Factor | 2002 |
Therapeutic concentrations of raloxifene augment nitric oxide-dependent coronary artery dilatation in vitro.
Topics: Animals; Bradykinin; Coronary Vessels; Estradiol; Estrogen Antagonists; Fulvestrant; In Vitro Techniques; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase Type III; Raloxifene Hydrochloride; Swine; Vasodilation; Vasodilator Agents | 2007 |